Video & Transcript : 'FDA user fees' :

Page 36 of 500
WA

Washington 2025-2026 Regular Session

House Health Care & Wellness Feb 25th, 2026 at 01:30 pm

Health Care & Wellness

Transcript Highlights:
  • So that includes HCA's authority to establish the fees, reporting regarding the fees, and the dedicated
  • account for the fees.
  • With new fees come additional costs, and I would hope... ...fee.
  • these fees to be deposited in that space.
  • FDA regulated.
Bills: SB5877
WA

Washington 2025-2026 Regular Session

House Health Care & Wellness Feb 25th, 2026

Transcript Highlights:
  • So that includes HCA's authority to establish the fees, reporting regarding the fees, and the dedicated
  • account for the fees.
  • With new fees come additional costs, and I would hope. lien fee.
  • these fees to be deposited in that space.
  • FDA regulated.
Summary: The Health Care and Wellness Committee heard executive action on seven bills, with discussion focused on prior authorization, the 340B drug pricing program, biosimilars, HIV drug coverage, exchange certification criteria, and hearing/speech board authority. Members also considered several amendments, including a date change to prior authorization reporting in SB 5395, a large striking amendment and multiple policy amendments on SB 5981, and market-criteria amendments on SB 6210. Testimony and debate centered on transparency, administrative costs, rural access, patient care spending, market stability, and the balance between state authority and federal law. SB 5395 on prior authorization received Amendment 247, which moved the carrier reporting deadline to the Office of Insurance Commissioner from January 1, 2027 to October 1, 2026, and was then reported out with a due pass recommendation. SB 5981 on 340B drug pricing adopted a striking amendment creating reporting and fee structures, but rejected amendments that would have removed filing fees, required 90% of revenues to go to direct patient care, limited additional contract pharmacies to rural or underserved areas, or delayed the bill’s effective date; the bill then passed out of committee 11-7. Supporters emphasized transparency and safety-net funding, while opponents raised concerns about federal preemption, litigation, costs, and administrative burden. SB 5594 on biosimilar substitution, SB 5877 on certified anesthesiology assistants and the physician health program, and SB 6183 on coverage of FDA-approved HIV antiviral drugs without utilization management all advanced with broad support and due pass recommendations. SB 6210 on health benefit exchange market factor criteria adopted a striking amendment but rejected amendments that would have limited updates to every two years, narrowly defined “meaningfully different,” or changed implementation timelines; it also passed 11-7. SB 6226 on the Board of Speech and Hearing adopted Amendment 313 to expand standards-of-care authority for hearing aid fitting and dispensing, then passed 17-1 after debate about patient safety, tele-audiology, and access to care.
US
Transcript Highlights:
  • So let me read again: promise that the FDA will not deprioritize our delay review and our approval of
  • Are you aware of the FDA post-approval monitoring? I'm aware of only two systems.
  • I have given away all of my rights to anti-fees in that lawsuit. I yield back.
  • We have 10,000 ingredients in our food in this country because the FDA employs a standard called the
  • We are attracting the most talented group of people who work in NIH, CDC, and FDA in modern history.
HI

Hawaii 2025 Regular Session

JHA Info Briefing - Wed Jan 29, 2025 @ 2:00 PM HST

Hawaii House Floor Meeting

Transcript Highlights:
  • ><c> be</c><00:28:54.440><c> accompanied</c><00:28:54.919><c> by</c><00:28:55.000><c> a</c> waving fees
  • and must be accompanied by a waving fees and must be accompanied by a robust<00:28:55.559><c> and</c
  • However, the FDA still retains authority over products, and the FDA has been very clear that hemp-specific
  • And if it's a drug, they do have several approved FDA-approved drugs. prohibition on that so hopefully
  • But the FDA is very clear that you cannot have hemp-derived cannabinoids in food or in supplements.
TX

Texas 89th Regular

Public Health Mar 10th, 2025

Public Health

Transcript Highlights:
  • They already have been approved. by the FDA as a medical food for the treatment of dementia.
  • However, I have to say the FDA doesn't like that.
  • The FDA would have not given this.
  • Personally, the difference between FDA cleared and FDA approved? Really great question.
  • The first one who did it got FDA approval.
Bills: HB5 , HJR3 , HB155 , HB513 , HB5 , HB155
Committee: House Public Health
LA

Louisiana 2026 Regular Session

Senate May 20th, 2026

Louisiana Senate Floor Meeting

Transcript Highlights:
  • of vehicle liability security to provide for a decrease in reinstatement fees.
  • It's the same bill as last time, but there is a fee on this.
  • So with all of the amendments that were added in the House, there is a fee.
  • This bill just allows them to raise the fee by $3.50. I see no questions.
  • This is basically a correction in fees that have been at the same level since 2015.
Bills: SR130 , SR131 , SR132 , SR133 , SCR74 , SCR12 , HB582 , HB221 , HCR74 , HCR58 , HB71 , HB79 , HB158 , HB160 , HB169 , HB227 , HB251 , HB289 , HB330 , HB394 , HB410 , HB429 , HB769 , HB1017 , HB1234 , HB712 , SCR3 , SB54 , SB72 , SB129 , SB164 , SB232 , SB287 , SB322 , SB374 , SB375 , SB386 , SB409 , SB447 , SB458 , SB78 , SB112 , SB124 , SB125 , SB174 , SB190 , SB201 , SB208 , SB236 , SB273 , SB307 , SB347 , SB357 , SB385 , SB387 , SB393 , SB401 , SB415 , SB426 , SB435 , SB487 , SB488 , SB523 , SB222 , SCR9 , SCR58 , SB480 , SB514 , SB35 , SB65 , SB215 , SB246 , SB249 , SB269 , SB282 , SB296 , SB323 , SB363 , SB369 , SB474 , SB490 , SB492 , SB500 , HCR31 , HCR47 , HB362 , HB363 , HB368 , HB377 , HB380 , HB382 , HB386 , HB392 , HB406 , HB431 , HB441 , HB466 , HB503 , HB533 , HB559 , HB575 , HB590 , HB593 , HB618 , HB655 , HB664 , HB685 , HB692 , HB707 , HB715 , HB732 , HB738 , HB741 , HB748 , HB776 , HB807 , HB822 , HB856 , HB860 , HB868 , HB887 , HB888 , HB905 , HB908 , HB961 , HB980 , HB990 , HB992 , HB999 , HB1000 , HB1010 , HB1146 , HB1157 , HB1233 , HB1243 , HB54 , HB137 , HB180 , HB192 , HB310 , HB321 , HB396 , HB512 , HB552 , HB578 , HB638 , HB663 , HB708 , HB717 , HB718 , HB1009 , HB1082 , HB1104 , HB1107 , HB1198 , HB1246 , HB27 , HB143 , HB205 , HB259 , HB267 , HB288 , HB308 , HB403 , HB405 , HB414 , HB417 , HB478 , HB546 , HB548 , HB555 , HB557 , HB609 , HB670 , HB672 , HB740 , HB779 , HB786 , HB796 , HB812 , HB848 , HB915 , HB917 , HB921 , HB930 , HB933 , HB1095 , HB1096 , HB1103 , HB1129 , HB1154 , HB1166 , HB1187 , HB1195 , HB1230 , HB316 , HB511 , HB514 , HB799 , HB1039 , HB17 , HB36 , HB41 , HB47 , HB73 , HB126 , HB133 , HB140 , HB159 , HB166 , HB211 , HB226 , HB271 , HB324 , HB337 , HB351 , HB399 , HB571 , HB723 , HB726 , HB750 , HB759 , HB844 , HB966 , HB1006 , HB1018 , HB1036 , SB29 , SB42 , SB43 , SB217 , SB274 , SB300 , SB379 , SB382 , SB441 , SB449 , HB134 , HB258 , HB359 , HB782 , SB149
NM

New Mexico 2025 Regular Session

IC - Tobacco Settlement Revenue Oversight Nov 14th, 2025

Tobacco Settlement Revenue Oversight Committee

Transcript Highlights:
  • They do have applications for modified risk tobacco products with the FDA now.
  • They have yet to be evaluated by the FDA in completion.
  • Claims about the FDA no longer having authority or the FDA having safe harbor for products in pending
  • No, we have direct statements from the FDA, the Center for Tobacco Products.
  • I've been approved by the FDA, and then so you get a quick overview.
NH

New Hampshire 2025 Regular Session

Senate Health and Human Services (04/02/2025)

Health and Human Services

Transcript Highlights:
  • </c> 1800 bad drug and report it to the FDA 1800 bad drug and report it to the FDA because<00:04:41.000
  • So thank you very much. review the FDA guideline with parents review the FDA guideline with parents and
  • </c> on the FDA on the FDA website<02:01:14.639><c> so</c><02:01:15.119><c> thank</c><02:01:15.280><c
  • Representative Cordelli said he did not believe so, because the FDA guidelines are available on the FDA
  • </c><02:06:53.119><c> medication</c> couple um one is so the FDA medication couple um one is so the FDA
OK

Oklahoma 2026 Regular Session

Business and Insurance 2ND REVISED Feb 12th, 2026 at 09:30 am

Business and Insurance

Transcript Highlights:
  • is a long time coming work by the Construction Industries Board and their chairman to update their fees
  • So all these fee increases are based literally on a formula that the chairman of the CIB came up with
  • So they waited until they absolutely needed our help to raise some fees in order to put them on a trajectory
  • They have different fee schedules. So, is it possible? It is.
  • as a convenience fee.
OK
Transcript Highlights:
  • Clerk will read House Bill 3262 by George of the House and Hines of the Senate, an act relating to fees
  • It's about the fee charged for warrant services that's been the same since 2006 at $50 dollars and this
  • If I recall, this has a fee reduction as part of it, and if that's correct, what was that fee doing,
  • It's not lowering the Fee.
  • That's the current fee structure. Not see any other Questions.
LA

Louisiana 2026 Regular Session

House of Representatives Apr 29th, 2026

Louisiana House Floor Meeting

Transcript Highlights:
  • , that's automatic dependent surveillance broadcast, one dealing with airports and the charges and fees
  • and prohibiting certain entities from using certain data as a basis for calculating or collecting fees
  • That was one dealing with airports and the charges and fees on that. Rep. Green, one minute.
  • regulations, prohibit certain entities from using certain data's basis for calculating collecting fees
  • We know that PBMs hide behind the shadows as it relates to a lot of their fees, and this bill simply
OK

Oklahoma 2026 Regular Session

Energy REVISED Apr 23rd, 2026 at 09:30 am

Energy

Transcript Highlights:
  • said, I don't know what the final product's going to be, but there are options to work With high load users
  • But you know, at the end of the Day, it's always the end user that's going to pay for it.
  • the word 'or' and before the word 'illo', the words 'USF funded' and inserting the words 'large load user
  • That's a large load user to put in the bill.
Committee: Senate Energy
LA

Louisiana 2026 Regular Session

Commerce Apr 7th, 2026

Commerce

Transcript Highlights:
  • It takes the fees out, for one.
  • to that user?
  • When you're sharing the location of a minor user, that can be dangerous.
  • Increasing fees for pyrotechnic special effects operators.
  • I didn't realize the permit fee was so low.
Bills: HB461 , HB467 , HB522 , HB565 , HB673 , HB799 , HB917 , HB937 , HB956 , HB977
AZ

Arizona 2026 Regular Session

02/10/2026 - Senate Natural Resources

Natural Resources

Transcript Highlights:
  • reports, and then the water users pay the fee, typically in March.
  • So the withdrawal fee, the total withdrawal fee, I don't know the... Mr. Chair, Senator Gabaldón.
  • So the withdrawal fee, the total withdrawal fee, I don't know the answer to that.
  • It's gotten very confusing how you have a small fee over here, and then you have a $500 fee over here
  • It's got very consuming how, confusing how you have a small fee over here, and then you have a $500 fee
WA

Washington 2025-2026 Regular Session

Senate Agriculture & Natural Resources Feb 2nd, 2026 at 01:30 pm

Agriculture & Natural Resources

Transcript Highlights:
  • requirements required by either Ecology or Fish and Wildlife exceeds the cost of a typical mitigation fee
  • Senate Bill 6318 caps shellfish licensing, biotoxin, and export fees at designated levels.
  • and the fee maximums established in this bill at approximately $4.7 million over the four-year outlook
  • Is there a discussion on this shellfish fee bill? We held a work session, had a lot of input.
  • that will damage their ability to conduct business in the state. ...growers not have fees that will